The Period Care Company Emerges from Stealth with Launch of Secure Period Tracking App

NASHVILLE, Tenn., Feb. 5, 2025 — Comma, a female-founded integrated period care company, proudly announces the launch of its secure period tracking app, Sara™, alongside a $2 million seed funding round.

From the rollback of Roe v. Wade to the recent shutdown of ReproductiveRights.gov, the future of reproductive health in America is riddled with concerns about data privacy and access. Comma aims to set a new standard and provide users with safe, secure and unbiased information about their health. The Tennessee-based company is harnessing the power of periods to bring predictive, personalized science to reproductive health through the use of secure technology and sustainable consumer product goods. Led by a team of reproductive health and cyber security experts, Comma has spent the last two years innovating and developing technology and consumer products that put autonomy at the forefront.

Comma graduated from the Techstars Physical Health accelerator in 2023, and Techstars venture fund followed on in this latest funding round. More than 50% of Comma’s seed investors are women, which reflects the company’s commitment to prioritizing reproductive health by centering those most impacted at every level.

“Comma is approaching menstrual health in a holistic way that hasn’t been done before in the consumer products and technology space,” said Trey Bowles, Managing Director of Techstars Physical Health. “We’re proud to invest in a more secure, sustainable future through this partnership.”

Alongside this round of funding, Comma launches its flagship product Sara™, a secure period tracking and disease detection app. Now available publicly, the platform helps users uncover patterns and concerns in their menstrual cycle, connecting them to relevant care partners and arming them with the data and knowledge needed to take control of their reproductive health. After conducting user beta testing, the Comma team was able to further innovate several functionalities, including a secure pregnancy tracking mode that emerged as an end-user priority.

Because Comma believes that period data is just as much personal health information as clinical trial findings or laboratory test results, they’ve invested in industry-leading security and privacy protocols to keep user data within Sara™ as safe as possible. By looking to HIPAA and healthcare best practices, Sara™ is more than just a period tracking app: it’s a safe and secure dashboard for a user’s reproductive health. Sara™ was thoughtfully built as a progressive web app (PWA), meaning users access the dashboard through an internet browser rather than downloading it to their phone from an app store. This ensures that users’ metadata is never tracked, and all information is kept strictly private.

“People shouldn’t have to choose between a better understanding of their bodies and the threat of surveillance, ” said Miller Morris, M.A., M.P.H., founder and CEO of Comma. “That is why we built Comma with security and autonomy at the forefront. Even as policies restricting reproductive rights surface, we remain committed to protecting user data and building community. Consumers deserve better, period.”

Beyond the technology, Comma has plans to revolutionize reproductive health in a variety of ways, including building out the ability to use the menstrual blood in a tampon to screen for potential reproductive health complications and beyond. With two team members sitting on the ISO/TC 338, Comma also plans to release the first-ever biodegradable single-use period product. Made with a compostable plant-based bio-resin applicator and 100% organic cotton, Comma is one step closer to changing menstrual healthcare for the better. In the future, Comma will launch its send-back diagnostics service, redirecting period products from the landfill to the lab to pioneer the use of menstrual blood biomarkers in healthcare.

For more information about Comma or to join Sara™, visit www.yourcomma.com/meet-sara.

About Comma
Comma is an integrated period care company. Founded and built by experts in reproductive health, Comma combines software, sustainable tampon products, and laboratory diagnostics to bring personalized and predictive medicine to reproductive care. Its flagship product, Sara™, is a hyper-secure period tracking app that uses HIPAA-based best practices as a benchmark for its data privacy and security standards. Sara™ helps users uncover patterns and concerns in their menstrual cycles and connect with relevant care partners. Comma is on a mission to transform reproductive health one period at a time. Learn more at yourcomma.com.

Media Contact
[email protected]

SOURCE Comma

• Rasmal Ventures inaugural VC fund is the first fund to join the $1 billion venture capital program from QIA  
• Qatar-based VC firm Rasmal Ventures launched its home-grown fund in June 2024 to drive innovation and investment in Qatar and the MENA region  
• Commitment from QIA’s Fund of Funds program will enable the fund to grow its presence across the region and execute the highly selective investment strategy  

DOHA, Qatar, Feb. 5, 2025 — Rasmal Ventures LLC, Qatar’s first independent venture capital (VC) company, which was established in 2023, has today announced funding from QIA as part of its Fund of Funds program.  

The funding is received into Rasmal Venture’s inaugural, home-grown venture capital fund, Rasmal Innovation Fund I LLC which targets high-performance startups and scales up across a variety of innovative technology sectors, including fintech, B2B SaaS, HealthTech and AI.  

Rasmal Innovation Fund I LLC is the first fund announcement as part of QIA’s $1 billion Fund of Funds program announced as open to applicants in February 2024.  

To date, the Rasmal Innovation Fund I LLC has closed funding from QIA’s Fund of Funds, corporates, family offices and individual high-net-worth investors with an aim to reach $100 million in investment commitments. The Fund is only open to professional investors as defined in QFCRA regulation. 

Alexander Wiedmer, Co-Managing Partner of Rasmal Ventures, said “As the first private VC fund based in Doha, we have forged strong partnerships with leading Qatari institutions to work closely with exceptional founders, stimulate innovation, and meet the region’s unique needs. While still in the early stages of capital deployment, we take pride in our first investments in proprietary tech startups. The trust QIA and our other investors placed in us is a testament to our team’s capabilities and dedication. We will continue to grow our presence across the region and execute our highly selective investment strategy to establish ourselves as a key player in the MENA VC landscape.” 

The Rasmal Innovation Fund I LLC is managed by a highly experienced team of VC experts that have collectively managed more than 100 VC deals, along with impressive exits.  

About Rasmal Ventures Innovation Fund I LLC   

The Rasmal Ventures Innovation Fund I LLC targets investments in innovative and high-performance technology startups and scaleups across Qatar, the wider Middle East and North Africa (MENA) region, and internationally at pre-Series A, Series A and Series B stages. While the fund will scout all technology sectors agnostically, it will have a strategic interest in  fintech, supply chain logistics, HealthTech, B2B SaaS and Artificial Intelligence (AI).  

The launch of Rasmal Innovation Fund I LLC aligns firmly with the country’s Third National Development Strategy (NDS3) as it aims to contribute to the creation of a buoyant tech ecosystem which is underpinned by easy access to a range of investment and funding opportunities.  

About QIA’s Fund of Funds Program   

The Fund of Funds program aims to develop a strong start-up and venture capital ecosystem in Qatar, attract leading venture capital funds and entrepreneurs to the region and help close the current funding gap for local and regional entrepreneurs.  

The program, first announced in February 2024, will invest more than USD 1 billion in international and regional venture capital funds and will place a priority focus on the tech and healthcare sectors.  

The Fund of Funds program has a dual investment mandate to achieve good financial performance and deliver a positive development impact on the Qatari venture capital ecosystem. 

SOURCE Rasmal Ventures

New funding to be used to expand Lorikeet’s platform and market presence, helping more companies across complex and regulated industries use AI agents to offer human quality support at scale 

SYDNEY, Feb. 4, 2025 — AI customer experience pioneer Lorikeet today announces it has raised an additional AUD $9 million in funding from Blackbird and its existing investors Square Peg and Skip Capital, fueled by breakout growth in 2024 across key financial centers in Australia, Asia, and the US and just four months after announcing its USD $5 million seed round fundraise last year. 

Since launching in October 2024, Lorikeet has increased bookings by 3.5 times, and added several unicorns and public companies in the US and Australia as customers and pilot partners, including market leaders such as Eucalyptus in healthcare, Step in banking, and MagicEden in Cryptocurrency. The new funding will be used to further enhance Lorikeet’s intelligent graph technology, expand the company’s enterprise capabilities, and accelerate go-to-market initiatives across key industries including healthcare, financial services, technology, and more.

Customer experience as we know it is broken. Support teams are scattered across time zones, struggling with sky-high turnover rates while customers wait hours or days for help. Basic AI chatbots have failed to fix the problem – they’re too rigid to handle anything beyond simple FAQ responses. Even highly funded Silicon Valley darling startups have failed to ship products that can reliably handle complex support cases. Lorikeet is changing that with an AI platform that doesn’t just match human agents, but can also uniquely handle complex support queries involving confidential patient information, movement of digital currencies, and more.

“We’re not satisfied with using AI to simply summarize FAQs, or implementing architectures passed on by OpenAI,” said Steve Hind, Lorikeet’s co-founder and CEO. “Our intelligent graph architecture is purpose-built ground up to enable AI agents to reliably handle complex workflows  in highly regulated industries that were previously impossible for AI to handle.”

The company’s proprietary intelligent graph technology orchestrates sophisticated workflows for tasks ranging from secure credit card replacements to effective triage of medical issues and cryptocurrency transaction verification. Lorikeet’s AI agents are distinctive in their ability to deliver high quality interactions on complex, multi-conditional customer problems, engage on highly sensitive or regulated topics, while knowing what they don’t know, so that they can avoid giving incorrect answers.

Eucalyptus, a global telehealth player, increased customer satisfaction scores (CSAT) by 10 points while doubling support volume in a year without growing the team. Magic Eden, a top NFT Hub who was facing surges in support volume due to the cryptocurrency bull market and increased interest and usage of their mobile app, adopted Lorikeet to handle the volume while seeing CSAT increase to 75%, up from 45% with their previous AI agent provider. Breeze, APAC-based fintech, was able to independently resolve 40% of their complex support volume with Lorikeet within 30 days, including questions about KYC reviews, transaction statuses and declines.

Global Growth From Down Under

“The Australian technology ecosystem continues to produce world-class innovations in artificial intelligence, and Lorikeet stands out as a prime example,” said Tom Humphrey, Partner at Blackbird. “The team’s product approach to solving complex customer support challenges through advanced AI workflows is differentiated. Support is perhaps the highest impact and lowest hanging fruit opportunity for enterprise adoption of AI, and the market scale is absolutely enormous.”

Lorikeet has seen strong traction globally, with special momentum in the U.S. across healthcare providers, financial institutions, and technology companies. The company has plans to aggressively expand into the United States, while also growing its local team in Sydney.

“What sets Lorikeet apart is our fundamental understanding that effective customer support requires more than just conversational AI,” said Jamie Hall, Co-founder and CTO of Lorikeet. “Our intelligent graph technology is unique in its ability to both solve complex customer inquiries and know what it doesn’t know to avoid giving incorrect answers or engaging on highly sensitive or regulated topics.”

For more information about Lorikeet’s AI-powered customer support platform, visit www.lorikeetcx.ai.

About Lorikeet

Lorikeet is revolutionizing customer experience with the most powerful AI support platform on the market. Through its pioneering intelligent graph technology, Lorikeet enables enterprises to deliver consistent, high-quality customer support at scale. Founded in Sydney, Australia, Lorikeet serves global customers across healthcare, financial services, technology, and other industries where complex, secure customer interactions are mission-critical. Learn more at www.lorikeetcx.ai.

SOURCE Lorikeet

DENVER, Feb. 4, 2025 — Nextworld, a leading provider of enterprise platforms, today announced the successful closing of a $65 million Series F funding round. The investment, led by the McVaney Investment Partnership, positions the company for significant growth in 2025 as it continues to redefine how businesses build, extend, and optimize their technology stacks.

This latest round of funding underscores the McVaney Investment Partnership’s confidence in Nextworld’s innovative approach to enabling businesses with AI-driven solutions that address the modern demands of scalability, flexibility, and interoperability.

“We are thrilled to have the continued support of our investors as we enter a pivotal year,” said Kylee McVaney, CEO of Nextworld. “This funding will empower us to accelerate product innovation, expand our global footprint, and double down on our mission to help enterprises achieve the freedom of agility without the need for disruptive system overhauls.”

Aggressive growth plans for 2025
The funding will fuel Nextworld’s ambitious growth initiatives, including:

• Expanding strategic partnerships: Strengthening existing partnerships and forming new ones to deliver more pre-built integrations, deeper expertise, and innovative solutions for customers’ unique challenges.
• Driving innovation through RsD: Investing in cutting-edge technologies to further enhance the capabilities of its AI platform.
• Scaling go-to-market strategies: Amplifying marketing and sales efforts to reach more warehouse, finance, operations, and IT professionals worldwide.
• Building on customer success: Expanding proven customer satisfaction and retention by continuing to invest in value delivery, while preparing for growth in customer base and solution adoption.

Nextworld is gaining traction with enterprise customers across industries such as manufacturing, distribution, and software. Its platform is recognized for its ability to integrate seamlessly with existing ERP systems, enabling businesses to unlock new levels of efficiency without disrupting core processes.

“Nextworld is solving a massive problem for businesses facing the limitations caused by rigid legacy systems,” said Kevin McVaney, Managing Partner of the McVaney Investment Partnership. “We’re proud to support their vision and look forward to seeing them scale their transformative platform globally.”

About Nextworld
Nextworld is a leading enterprise platform provider, enabling businesses to create tailored software solutions that address their complex needs. From extending ERP functionality to driving intelligent process automation in inventory management and beyond, Nextworld empowers organizations to innovate and optimize. With no-code development, real-time data access, and seamless integrations, Nextworld helps businesses remain agile, competitive, and ready for the future.

For more information, visit www.nextw.com.

SOURCE Nextworld

SAN DIEGO, Feb. 4, 2025 — Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare, and Global Brain in this financing.

Zafrens’ breakthrough platform allows scientists to create and test hundreds of thousands of potential medicines in a single experiment – a dramatic improvement over traditional drug discovery methods. This innovative approach significantly reduces the time and cost of finding new treatments while providing deeper insights into how these drugs work.

“Our platform represents a fundamental shift in drug discovery,” said Swamy Vijayan, CEO of Zafrens. “By creating and testing hundreds of thousands of potential drugs simultaneously and understanding exactly how they affect cells, we can identify the most promising treatments faster and with greater confidence in their safety. This means we can potentially bring life-changing drugs to patients more quickly and efficiently.”

The company has already demonstrated the value of its platform through successful collaborations with several leading pharmaceutical companies, focusing on multiple classes of drugs. The new funding will enable Zafrens to expand its capacity and engage in additional partnerships with pharmaceutical companies worldwide.

“Zafrens exemplifies the kind of breakthrough innovation imec.xpand seeks to support,” said Benoit Devogelaere, Partner at imec.xpand. “Their platform is fundamentally enabled through nanotechnology, and can accelerate the development of various types of modern medicines, from traditional small molecule drugs to advanced cell therapies and antibody treatments. We’re excited to support their mission to transform how these new medicines are discovered.”

For more information, please contact:
Swamy Vijayan, CEO
[email protected]

About Zafrens Zafrens is pioneering an ultra-high-throughput drug discovery platform to isolate, culture, image, and sequence hundreds of millions of cells per project. The proprietary Z-Screen platform transforms drug discovery by enabling a comprehensive analysis of therapeutic assets across efficacy, safety, and mechanism dimensions. Alongside developing an internal pipeline, Zafrens collaborates with leading pharmaceutical companies to accelerate breakthroughs in oncology, immunology, neuroscience, and more disease areas. For more information, visit www.zafrens.com.

About imec.xpand imec.xpand is one of the world’s largest independent venture capital funds dedicated to early-stage semiconductor innovation. It targets ambitious deeptech start-ups where the knowledge, expertise and infrastructure of imec, the world-renowned semiconductor and nanotechnology R&D center, can play a determining role in their growth. imec.xpand has an outspoken international mindset towards building disruptive global companies and strongly believes that sufficient funding from the start is key to future success.

SOURCE Zafrens

Atombeam Makes Handling Data Faster, More Efficient and More Secure, Addressing the Surge in Edge Computing and Growth of Information Availability

MORAGA, Calif., Feb. 4, 2025 — Atombeam, whose innovative technology redefines how data is used, moved, stored and secured, today announced the closing of its recent Reg A+ funding round, with a total of $20 million raised. The successful funding round was hosted by StartEngine, empowering ordinary, individual investors to gain an ownership stake in the company’s transformative technology. More than 6,500 investors invested in Atombeam during this round. This brings Atombeam’s total funding to $35 million.

“Our technology has been engineered to completely transform data and the way it is used, making it more efficient and secure without compromising the ability to process it,” said Charles Yeomans, CEO and Chairman of Atombeam. “By reducing data size by 75% in a few millionths of a second, bandwidth can be expanded by 4x – which means companies can access more data, faster, and less expensively. By doing so, fewer energy and infrastructure resources are necessary, even while the amount of data being accessed, transmitted and used increases.”

Atombeam’s revolutionary technology is called “Data-as-Codewords,” which uses cryptography and compression to translate data into a set of codewords within an AI/ML-created codebook. A customer then sends and stores their codewords along an event path, for use by a reader application. There, the data is accessed and used through the same codebook, directly in its transformed state. Data-as-Codewords is always compressed, always encrypted, and transmits the data without latency, ensuring transmission and storage is always optimized.

Atombeam plans to use the funding to continue growing the organization, adding to both the go-to-market and research and development parts of its team. The funding will also be used to further develop its Neurpac and Neurcom products, incorporating customer feedback and ensuring that both exceed the expectations of its growing customer base.

Over the course of the past year, Atombeam has continued its momentum, securing new customer implementations and product recognition. To date, Atombeam has been issued more than 84 patents for its technology, with an additional 115 pending. The company is a technology partner with Ericsson Enterprise Wireless Solutions and Viasat’s ELEVATE Partner Program, and its technology was recently chosen by the United States Air Force. Atombeam’s innovative approach to solving the data problem was also recognized with the Gold Award for Technology Innovation by the Merit Awards for Technology, and with a Gold Award for Disruptor Company in Business Products or Services by the Globee Awards for Business.

For more information on Atombeam and how its technology is changing the way data is used by companies, please see its recent explainer video here.

About Atombeam
Atombeam has the potential to revolutionize data management through its Data-as-Codewords Neurpac technology, altering how data is encoded, used, transferred, managed, stored and secured. Atombeam increases available bandwidth an average of 4x, improves access to stored data by making it searchable while encoded, and enhances security with ultralight software, all in a single computing step. Atombeam’s Neurpac is uniquely capable of operating on the smallest machine-generated or Internet of Things data, which is not possible with compression. For more information, please visit www.atombeamtech.com or follow us on LinkedIn, Facebook or YouTube.

Media Contact:
Jeff Drew
Guyer Group for Atombeam
P: 617.233.5109
E: [email protected]

This Reg. A+ offering is made available through StartEngine Primary, LLC, member FINRA/SIPC. Please read the Offering Circular and Risk Factors disclosure before investing. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

SOURCE Atombeam

Startup raises a total of $11.5 M to develop new SaaS technology 

NEW YORK, Feb. 4, 2025 — Now, more than ever, supply chain operators need a tool that helps them predict and understand disruptions and gives them the power to plan accordingly. In the last twelve months, the Suez Canal was blocked by Houthi rebels, historic drought in the Panama Canal decreased the number of crossings from the Atlantic to the Pacific Ocean, protests at U.S. ports halted shipments, 11 hurricanes impacted trade routes and there is the threat of tariffs against top trading partners.

Desteia, a New York-based startup with operations in the U.S. and Mexico, leverages cutting-edge technology to support leaders and operators, giving them the tools to make optimal decisions for their supply chain in a context of continuous disruptions. The company has secured $8 million in a seed funding round led by Autotech Ventures, Nazca, and Village Global, positioning the company to revolutionize logistics operations with new artificial intelligence tools and graph theory. The round, which brings Desteia’s total funding to $11.5 million, included participation from Foundamental, Bridge Latam, and Nido Ventures.

The additional funding will enable Desteia to focus on U.S.-Mexico trade, where companies move over $850 billion worth of goods annually. Working with customers worldwide, Desteia will provide better visibility to their operations and suggest the most efficient decisions to operators.

Desteia, founded by former Tesla executive Françoise Lavertu and Stanford engineers and entrepreneurs Diego Solorzano and Austin Poore, simplifies logistics by using AI to extract and organize information from unstructured data like emails, messages, and logistics documents. It connects these pieces together using graph theory, the mathematical study of networks—comprising nodes (locations) and edges (routes), creating a clear dashboard for operators to manage shipments across ocean, ground, and air with specific expertise on U.S.-Mexico cross-border operations. This includes integrations to Mexico’s customs system to give further visibility to shipments at port or at the border.

“As we evaluate hundreds of supply chain tech solutions every year, Desteia stood out with its unique approach to extracting unstructured data, which truly feels like magic,” said Burak Cendek, partner at Autotech Ventures. “Unfortunately, traditional communication channels such as email and text are not going away, but recent advances in AI make it possible to meet customers where they are.”

Desteia’s goal is to be the decision-making tool for supply chain operators. With minimal integration effort, the dashboard data provides actionable insights for logistics teams to securely access real-time updates on container ETAs, predict potential disruptions, and identify opportunities for optimization, such as the best carriers or most efficient routes.

“Decision-makers have access to many think tank risk reports but lack the tools to incorporate them into their specific supply chain decisions,” said Lavertu. “We have developed a practical platform that helps them solve this.” Adding that she’s faced those same challenges in her career as an operator and “never found solutions that were so easy to implement for a large organization.”

At the same time, for many operators, managing logistics involves manually handling thousands of emails and hundreds of documents monthly. One Desteia client reported managing 10,500 emails and 600 logistics documents each month. Desteia helps companies with these problems by automating data organization and analysis, allowing operators to focus on decision-making and strategic planning.

“Supply chain managers need oversight of the chain from one end to the other to anticipate delays and disruptions before they happen and before they have a negative impact,” said Solorzano. Disruptions are so common. In fact, it is estimated that companies lose between 3-5% of revenues from them.

Desteia has partnerships and contracts with major retailers, auto manufacturers, and CPGs in North America. Across the board, it has helped users, such as Elektra, one of the largest retailers in Latin America, achieve full visibility without any integrations required or manual work while reducing the time spent reviewing emails.

Adam Zobler, general partner at Foundamental said, “Relying on manual processes and fragmented communication systems means supply chains are fragile and prone to disruption. Desteia offers an exciting opportunity to streamline supply chains by harnessing the power of data.

“The founders are passionate, experienced, and inherently familiar with the problems they are tackling,” said Hector Sepulveda of Nazca. “We look forward to working with Diego, Austin, and Françoise to further develop the product and scale this technology to revolutionize global supply chain management.”

For more information about Desteia, visit desteia.com.

SOURCE Desteia

Leadership Changes to Drive Growth

SANTA ANA, Calif., Feb. 4, 2025 — The housing and mortgage industry faces rapid changes driven by rising interest rates, regulatory challenges, and the demand for digital solutions. Consolidated Analytics (CA) is responding with leadership updates to fuel growth and innovation. Rudy Zabran is transitioning from Chief Revenue Officer (CRO) to Chief Operating Officer (COO), and Steve Faulkner is stepping into the role of CRO. CA is setting the stage to lead during one of the most dynamic periods in the mortgage industry.

A Strategic Leadership Duo for a Changing Market
Rudy Zabran’s appointment as COO marks a decisive moment for CA. With a sharp focus on operational excellence, Zabran will drive the integration of proprietary technologies, streamline workflows, and deliver exceptional value to clients navigating the complexities of today’s housing market. Simultaneously, Steve Faulkner’s new role as CRO underscores CA’s commitment to client-centric strategies. By strengthening client relationships and aligning innovative solutions with industry demands, Faulkner will reinforce CA’s position as a trusted partner in the mortgage space. Together, their leadership promises to pave the way for innovation, and client success.

Expanding Business Development Expertise

In addition to these key leadership changes, CA is proud to announce the addition of two exceptional executives to its Business Development team: Darlene Swain and Sho Amiri.

CA welcomes two industry veterans to its Business Development team. Sho Amiri, with 25+ years of experience across mortgage, title, and capital markets, is known for managing multi-billion-dollar trades and delivering purpose-built client solutions. Sho’s deep understanding of the industry, from servicing and lending to title and due diligence, enables her to provide measurable value. Her dedication to client experience and result-driven strategies solidify her reputation as a trusted advisor and resource.

Darlene Swain is a mortgage industry leader with 20+ years of experience in consultative sales and risk management. She brings proven expertise in driving revenue and forging strategic partnerships with leading data and technology companies. Darlene’s strategic vision and innovative problem-solving skills make her an invaluable addition to CA’s team.

Both executives enhance CA’s ability to drive measurable value for clients. By prioritizing people and innovation, CA combines technology with human expertise to deliver transformative solutions.

A Vision for the Future
CA’s leadership changes and expanded expertise underscore its commitment to tackling industry challenges and redefining client success. With a focus on transformation, operational excellence, and innovation, CA is poised to shape the future of mortgage operations, delivering unparalleled solutions and partnerships.

About Consolidated Analytics, Inc.
Consolidated Analytics is an end-to-end mortgage services platform that delivers value to clients in origination, servicing, and capital markets, from asset-level analysis to enterprise optimization. A leading provider of real estate valuation, risk management, and advisory services, our comprehensive suite of solutions encompasses due diligence, residential and commercial valuation, collateral risk assessment, and regulatory compliance, enabling our clients to stay ahead in today’s dynamic market.

Jana Setterberg
Consolidated Analytics, Inc.
(303) 513-2459  I  [email protected] 

SOURCE Consolidated Analytics

With the new funding, PlantBaby will expand retail distribution, accelerate innovation, and continue to grow its team.

MARIN, Calif., Feb. 4, 2025 — PlantBaby, a pioneering company dedicated to creating innovative solutions in the plant-based nutrition space, proudly announces the successful close of its Series Seed equity financing round. The round was led by B2 Partners, a firm founded by seasoned investor Matt Behrens, at a post-money valuation of $20 million.

“PlantBaby represents the kind of forward-thinking, mission-driven company we look to support at B2 Partners,” said Matt Behrens, Founder of B2 Partners. “Their commitment to creating clean, plant-based nutrition solutions aligns perfectly with our belief in backing businesses that prioritize both health and sustainability. We’re proud to contribute to their journey and help them reach even more families in need of innovative nutrition options.”

This funding will empower PlantBaby to make its products more accessible around the country, through Sprouts, Wegmans, Amazon, Thrive, and their own Kiki Milk website built on Shopify. The new capital allows for further research and development and product innovation in both plant milk and new categories.

“We became acquainted with B2 Partners through an introduction by one of our early investors,” said Alex and Lauren Abelin, Co-Founders of PlantBaby. “Their decision to lead this funding round underscores their confidence in PlantBaby’s vision and potential. We’re thrilled to join forces with such an excellent and thoughtful partner.”

B2 Partners led the seed round and is joining the PlantBaby board, with additional support from Big Idea Ventures, Everywhere Ventures, X Factor Ventures, Women’s Equity Lab Silicon Valley, and Babylist, bringing further momentum to the company’s growth journey.

Founders Lauren and Alex Abelin launched PlantBaby after their son Alakai’s birth, frustrated by the lack of clean-label and dairy-free infant formulas. Their company, PlantBaby, creates products they love and trust, aiming to support families everywhere, especially the 50% of children with chronic health conditions.

PlantBaby’s first product, Kiki Milk, launched in 2020 with Original and Chocolate and has expanded to include Mac Nut and Unsweetened. Unlike other plant milks, Kiki Milk is crafted with a blend of more than six whole food ingredients—free from seed oils, gums, artificial flavors, and preservatives. It is certified USDA Organic and glyphosate-residue free. Each serving naturally provides 5g of protein and contains an excellent source of calcium, thanks to unique nutrient-rich ingredients like sprouted pumpkin seeds, hemp seeds, and Aquamin™. To ensure the highest safety and quality, all varieties undergo third-party testing for heavy metals and mold, making Kiki Milk a clean and nourishing choice for the whole family.

“Improving the health of future generations is our North Star as both parents and entrepreneurs,” said Alex and Lauren Abelin. “We’re committed to providing the cleanest, most nutritious, and delicious products—for your family and ours—because every child deserves the best.”

For more information about Kiki Milk and its commitment to clean-label plant-based nutrition, visit www.kikimilk.com, www.plantbaby.co, or follow @kikimilkco on Instagram.

About PlantBaby
PlantBaby is a future-forward nutrition company creating clean-label, organic, plant-based foods, beverages, and supplements to support children from infancy to adulthood. Founded in 2020 in Kauai, Hawaii, PlantBaby is dedicated to improving the food system and prioritizes responsible sourcing. Its signature product, Kiki Milk, launched in December 2021 with Original and Chocolate blends, later expanding to include Mac Nut and Unsweetened. PlantBaby partners with Farmer’s Footprint and EcoCart to promote a healthier planet. Learn more at www.kikimilk.com, @kikimilkco, and www.plantbaby.co.

Press Contact:
AMC Consulting
Annmarie Mercieri Colonna
[email protected]
860-729-3323

SOURCE PlantBaby, Inc.